How a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendations

Published:2020-09 Issue:1-2 Volume:131 Page:211-218
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Ruskin Jeremy N.,Ortemann-Renon Catherine,Msihid Jerome,Ross Leorah,Puga Ana Cristina,Peterschmitt M. Judith,Cox Gerald F.,Maison-Blanche Pierre

Funder

Sanofi

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements;Grabowski;Eur. J. Pediatr.,2004

2. Gaucher disease;Grabowski,2013

3. Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat;Kamath;Skelet. Radiol.,2014

4. A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1;Lukina;Blood,2010

5. Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: final results from the phase 2 trial;Lukina;Am. J. Hematol.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158;Journal of Clinical Medicine;2023-05-04

2. Recomendaciones para el tratamiento oral de pacientes adultos con enfermedad de Gaucher tipo 1;Revista Clínica Española;2022-11

3. Recommendations for oral treatment for adult patients with type 1 Gaucher disease;Revista Clínica Española (English Edition);2022-11

4. Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions;Clinical Pharmacology & Therapeutics;2022-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3